chrX-77989631-G-A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000052.7(ATP7A):​c.1009G>A​(p.Ala337Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00084 in 1,209,928 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 333 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00067 ( 0 hom., 21 hem., cov: 22)
Exomes 𝑓: 0.00086 ( 0 hom. 312 hem. )

Consequence

ATP7A
NM_000052.7 missense

Scores

5
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 2.84

Publications

3 publications found
Variant links:
Genes affected
ATP7A (HGNC:869): (ATPase copper transporting alpha) This gene encodes a transmembrane protein that functions in copper transport across membranes. This protein is localized to the trans Golgi network, where it is predicted to supply copper to copper-dependent enzymes in the secretory pathway. It relocalizes to the plasma membrane under conditions of elevated extracellular copper, and functions in the efflux of copper from cells. Mutations in this gene are associated with Menkes disease, X-linked distal spinal muscular atrophy, and occipital horn syndrome. Alternatively-spliced transcript variants have been observed. [provided by RefSeq, Aug 2013]
PGK1 (HGNC:8896): (phosphoglycerate kinase 1) The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. Additionally, this protein is secreted by tumor cells where it participates in angiogenesis by functioning to reduce disulfide bonds in the serine protease, plasmin, which consequently leads to the release of the tumor blood vessel inhibitor angiostatin. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Deficiency of the enzyme is associated with a wide range of clinical phenotypes hemolytic anemia and neurological impairment. Pseudogenes of this gene have been defined on chromosomes 19, 21 and the X chromosome. [provided by RefSeq, Jan 2014]
PGK1 Gene-Disease associations (from GenCC):
  • glycogen storage disease due to phosphoglycerate kinase 1 deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.02700618).
BP6
Variant X-77989631-G-A is Benign according to our data. Variant chrX-77989631-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 377535.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 75 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP7ANM_000052.7 linkc.1009G>A p.Ala337Thr missense_variant Exon 4 of 23 ENST00000341514.11 NP_000043.4 Q04656-1B4DRW0Q762B6
ATP7ANM_001282224.2 linkc.1009G>A p.Ala337Thr missense_variant Exon 4 of 22 NP_001269153.1 Q04656-5B4DRW0Q762B6
ATP7ANR_104109.2 linkn.284+17870G>A intron_variant Intron 2 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP7AENST00000341514.11 linkc.1009G>A p.Ala337Thr missense_variant Exon 4 of 23 1 NM_000052.7 ENSP00000345728.6 Q04656-1

Frequencies

GnomAD3 genomes
AF:
0.000671
AC:
75
AN:
111853
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.000195
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00153
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000370
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000960
Gnomad OTH
AF:
0.000660
GnomAD2 exomes
AF:
0.000639
AC:
117
AN:
183142
AF XY:
0.000694
show subpopulations
Gnomad AFR exome
AF:
0.000152
Gnomad AMR exome
AF:
0.000182
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00102
Gnomad OTH exome
AF:
0.00111
GnomAD4 exome
AF:
0.000857
AC:
941
AN:
1098022
Hom.:
0
Cov.:
31
AF XY:
0.000859
AC XY:
312
AN XY:
363418
show subpopulations
African (AFR)
AF:
0.000152
AC:
4
AN:
26395
American (AMR)
AF:
0.000653
AC:
23
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.0000516
AC:
1
AN:
19380
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30197
South Asian (SAS)
AF:
0.00120
AC:
65
AN:
54142
European-Finnish (FIN)
AF:
0.000173
AC:
7
AN:
40526
Middle Eastern (MID)
AF:
0.000726
AC:
3
AN:
4135
European-Non Finnish (NFE)
AF:
0.000948
AC:
798
AN:
841950
Other (OTH)
AF:
0.000868
AC:
40
AN:
46090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
38
76
114
152
190
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000670
AC:
75
AN:
111906
Hom.:
0
Cov.:
22
AF XY:
0.000616
AC XY:
21
AN XY:
34104
show subpopulations
African (AFR)
AF:
0.000194
AC:
6
AN:
30894
American (AMR)
AF:
0.00153
AC:
16
AN:
10478
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2652
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3583
South Asian (SAS)
AF:
0.000371
AC:
1
AN:
2695
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6057
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.000960
AC:
51
AN:
53110
Other (OTH)
AF:
0.000652
AC:
1
AN:
1533
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000904
Hom.:
46
Bravo
AF:
0.000763
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000446
AC:
3
ExAC
AF:
0.000684
AC:
83
EpiCase
AF:
0.000709
EpiControl
AF:
0.00148

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 01, 2018
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 11, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19377476) -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jul 26, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

ATP7A-related disorder Benign:1
Nov 02, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Menkes kinky-hair syndrome;C0268353:Cutis laxa, X-linked;C1845359:X-linked distal spinal muscular atrophy type 3 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
13
DANN
Benign
0.96
DEOGEN2
Benign
0.41
.;T
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.88
D;D
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.027
T;T
MetaSVM
Uncertain
-0.042
T
MutationAssessor
Uncertain
2.2
M;M
PhyloP100
2.8
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-1.0
N;N
REVEL
Uncertain
0.31
Sift
Benign
0.21
T;T
Sift4G
Benign
0.54
T;T
Polyphen
0.014
.;B
Vest4
0.11
MVP
0.92
MPC
0.24
ClinPred
0.025
T
GERP RS
3.9
Varity_R
0.29
gMVP
0.38
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138039591; hg19: chrX-77245127; API